Robert Reindollar is a Gastroenterology physician affiliated with Gilead Sciences. OpenAlex indexes 62 publications with 12,270 citations (h-index 23). By OpenAlex citation count, this profile ranks in the top 10% of Gastroenterology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1809 Brenner Ave Ste 102
Salisbury, NC 281442567
Telephone
704-216-7071Provider last certified this registry record 5 Nov 2024.
Industry payments
22 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Intercept Pharmaceuticals, Inc.Program year202537 payments$48,027openpaymentsdata.cms.gov ↗
- ABBVIE INC.Program year202519 payments$12,155openpaymentsdata.cms.gov ↗
- Gilead Sciences, Inc.Program year202517 payments$10,382openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
86%Proton pump inhibitor52.3%Omeprazole68%Pantoprazole Sodium20%Dexlansoprazole Dr12%Part D<11 patientsAluminum Complex9%Sucralfate100%Part D<11 patients+ 3 more classes in this area
Cardiovascular
14%Aldosterone antagonist (MRA)14%Spironolactone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
John McHutchison, MD
Gilead Sciences
Jared Baeten, MD
Gilead Sciences
Joel Gallant, MD, MPH
Gilead Sciences
Wendy Verret
Gilead Sciences
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”